专题首页
会议简介
热门幻灯
专家访谈
热点聚焦
大会采风
精彩视频
壁板展示
专家报告
专家视点
AASLD
AASLD2013
AASLD2012
AASLD2011
AASLD2010
AASLD2009
AASLD2008
国际肝病
[AASLD2013]基于坏死炎症和肝脏硬度检测的亚洲慢性乙型肝炎患者重度肝纤维化的诊断指数
Diagnostic index for advanced liver fibrosis in Asian chronic hepatitis B patients based on necroinflammation and liver stiffness measurement 基于坏死炎症和....
[AASLD2013]肝上皮细胞祖细胞Hedgehog信号驱动妊娠免疫性肝病的实质纤维化
Hedgehog signaling by hepatic epithelial progenitor cells forming neotubles drives parenchymal fibrogenesis in gestational alloimmune liver di....
[AASLD2013]IFN-γ受体2基因变异与整体人群肝硬度相关:来自Rotterdam研究的结果
Gene variants in the interferon Gamma receptor 2 gene are associated with liver stiffness in the general population: results from the Rotterdam Study ....
[AASLD2013]Sofosbuvir(GS-7977)联合利巴韦林治疗24周后,HCV感染者肝脏移植术中移出的肝脏组织中核苷酸类似物水平
Nucleotide analog levels in liver explants from HCV infected subjects undergoing liver transplantation after up to 24 weeks Sofosbuvir(GS-7977) with r....
[AASLD2013]在中国汉族HBeAg阳性慢性乙型肝炎患者中,IL28B基因多态性与PEG-IFN治疗应答相关
Association of IL28B polymorphisms with peginterferon treatment response in Chinese Han patients with HBeAg-positive chronic hepatitis B 在中国汉族HBeAg阳性....
[AASLD2013]恩替卡韦或替诺福韦酯治疗慢性乙型肝炎时,亚裔患者的HBeAg血清学转换低于非亚裔患者
HBeAg seroconversion is lower in Asians vs non-Asians during treatment of chronic hepatitis B with entecavir(ETV) or tenofovir(TDF) 恩替卡韦或替诺福韦酯治疗慢性乙型肝....
[AASLD2013]Vaniprevir(MK-7009)治疗经治的基因1型HCV感染的肝硬化患者的药物暴露量高于非硬化患者
Vaniprevir(MK-7009) demonstrates higher exposures in treatment-experienced genotype(GT) 1 cirrhotic than non-cirrhotic HCV-infected patients Vaniprev....
[AASLD2013]分泌型卷曲相关蛋白5(Sfrp5)缺乏可引发小鼠一种脂肪细胞因子增强的carbon-retracholride性肝纤维化
Lack of secreted frizzled-related protein 5 (Sfrp5), an adipocytokine enhanced carbon-retracholride-induced liver fibrosis in mice 分泌型卷曲相关蛋白5(S....
[AASLD2013]脂毒性诱导的肝星状细胞激活、增生和迁移过程中肝细胞衍生微粒的释放
Hepatocyte-derived microparticles released during lipotoxicity induce hepatic stellate cells activation, proliferation and migration 脂毒性诱导的肝星状细胞激活、增生....
[AASLD2013]HBsAg阳性母亲所生新生儿的乙肝疫苗应答
Hepatitis B Vaccine Response among Infants Born to Hepatitis B Surface Antigen-Positive Women HBsAg阳性母亲所生新生儿的乙肝疫苗应答 点击查看原图
s
点击排行 Top Hits
[AASLD2013]代偿期肝硬化患者形成门…
[AASLD2013]扶正化瘀抗纤维化疗效经…
[AASLD2013]扶正化瘀为中药研究树立…
[AASLD2013]酒精性肝炎对治疗无反应…
[AASLD2013]慢性丙型肝炎对妊娠和围…
[AASLD2013]丙型肝炎治疗新药Sim…
[AASLD2013]钾离子通道基因KCNJ…
[AASLD2013]适度饮酒降低非酒精性脂…
[AASLD2013]酒精性肝炎管理中的争议
[AASLD2013]乙肝免疫治疗新药TG1…
[AASLD2013]IL28B基因型以及I…
[AASLD2013]抗病毒药联合中药可加速…
[AASLD2013]基于人类全基因组关联分…
[AASLD2012]慢性乙型肝炎的治疗现状…
[AASLD2013]基于坏死炎症和肝脏硬度…
[AASLD2013]人肝脏PPAR表达与组…
[AASLD2013]临床试验是中药国际化的…
[AASLD2012]急性自限性和慢性HBV…
[AASLD2013]再生医学研究的目的是避…
[AASLD2013]拉米夫定单药治疗长期预…
关于本站
|
设为首页
|
加入收藏
|
站长邮箱
|
友情链接
|
版权申明
国际肝病 版权所有  2004-2013 ihepa.com All Rights Reserved